Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: High glucose suppresses sEH expression

Drug Metabolism and Pharmacokinetics

Volumn 24, Issue 5, 2009, Pages 438-445

  Oguro, Ami ^a   Fujita, Natsuko ^a   Imaoka, Susumu ^a  

^a KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Cytochrome P450; Diabetes; Epoxyeicosatrienoic acid (EET); High glucose; Soluble epoxide hydrolase

Indexed keywords

DIPHENYLIODONIUM SALT; EPOXIDE HYDROLASE; GLUCOSE; HYDROGEN PEROXIDE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SOLUBLE EPOXIDE HYDROLASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME REGULATION; GENE EXPRESSION; GLOMERULUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY PROXIMAL TUBULE; LIVER LEVEL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; STREPTOZOCIN DIABETES; TISSUE DISTRIBUTION;

EID: 71449124588     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.24.438     Document Type: Article

References (41)

1. Morisseau, C. and Hammock, B. D.: Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu. Rev. Pharmacol. Toxicol., 45: 311-333 (2005).
2. Guengerich, F. P. and Shimada, T.: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol., 4: 391-407 (1991).
3. Chacos, N., Capdevila, J., Falck, J. R., Manna, S., Martin-Wixtrom, C., Gill, S. S., Hammock, B. D. and Estabrook, R. W.: The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. Arch. Biochem. Biophys., 223: 639-648 (1983).
4. Daikh, B. E., Lasker, J. M., Raucy, J. L. and Koop, D. R.: Regio-and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J. Pharmacol. Exp. Ther., 271: 1427-1433 (1994).
5. Rifkind, A. B., Lee, C., Chang, T. K. and Waxman, D. J.: Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch. Biochem. Biophys., 320: 380-389 (1995).
6. Campbell, W. B., Gebremedhin, D., Pratt, P. F. and Harder, D. R.: Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res., 78: 415-423 (1996).
7. Fisslthaler, B. P. R., Kiss, L., Potente, M., Harder, D. R., Fleming, I. and Busse, R.: Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature, 401(6752): 6493-6757 (1999).
8. Zeldin, D. C.: Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem., 276: 36059-36062 (2001).
9. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol., 230: 215-221 (1993).
10. Spector, A. A. and Norris, A. W.: Action of epoxyeicosatrienoic acids on cellular function. Am. J. Physiol. Cell Physiol., 292: C996-1012 (2007).
11. Zeldin, D. C., Wei, S., Falck, J. R., Hammock, B. D., Snapper, J. R. and Capdevila, J. H.: Metabolism of epoxyeicosatrienoic acids by cytosolic epoxide hydrolase: substrate structural determinants of asymmetric catalysis. Arch. Biochem. Biophys., 316: 443-451 (1995).
12. Zeldin, D. C., Kobayashi, J., Falck, J. R., Winder, B. S., Hammock, B. D., Snapper, J. R. and Capdevila, J. H.: Regio-and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase. J. Biol. Chem., 268: 6402-6407 (1993).
13. Shimojo, N., Ishizaki, T., Imaoka, S., Funae, Y., Fujii, S. and Okuda, K.: Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochem. Pharmacol., 46: 621-627 (1993).
14. Imaoka, S., Nakamura, M., Ishizaki, T., Shimojo, N., Ohishi, N., Fujii, S. and Funae, Y.: Regulation of renal cytochrome P450s by thyroid hormone in diabetic rats. Biochem. Pharmacol., 46: 2197-2200 (1993).
15. Imaoka, S. and Funae, Y.: Induction of cytochrome P450 isozymes in rat liver by methyl n-alkyl ketones and n-alkylbenzenes. Effects of hydrophobicity of inducers on inducibility of cytochrome P450. Biochem. Pharmacol., 42: S143-150 (1991).
16. Kato, R. and Yamazoe, Y.: Sex-specific cytochrome P450 as a cause of sex-and species-related differences in drug toxicity. Toxicol. Lett., 64-65: 661-667 (1992).
17. Agrawal, A. K. and Shapiro, B. H.: Intrinsic signals in the sexually dimorphic circulating growth hormone profiles of the rat. Mol. Cell. Endocrinol., 173: 167-181 (2001).
18. Imaoka, S., Yamazoe, Y., Kato, R. and Funae, Y.: Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary. Arch. Biochem. Biophys., 299: 179-184 (1992).
19. Kimura, S., Hanioka, N., Matsunaga, E. and Gonzalez, F. J.: The rat clofibrate-inducible CYP4A gene subfamily. I. Complete intron and exon sequence of the CYP4A1 and CYP4A2 genes, unique exon organization, and identification of a conserved 19-bp upstream element. DNA, 8: 503-516 (1989).
20. Moody, D. E., Loury, D. N. and Hammock, B. D.: Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate], a peroxisome proliferator. Toxicol. Appl. Pharmacol., 78: 351-362 (1985).
21. Ohtoshi, K., Kaneto, H., Node, K., Nakamura, Y., Shiraiwa, T., Matsuhisa, M. and Yamasaki, Y.: Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients. Biochem. Biophys. Res. Commun., 331: 347-350 (2005).
22. Osada, M., Imaoka, S., Sugimoto, T., Hiroi, T. and Funae, Y.: NADPH-cytochrome P-450 reductase in the plasma membrane modulates the activation of hypoxia-inducible factor 1. J. Biol. Chem., 277: 23367-23373 (2002).
23. Imaoka, S., Hashizume, T. and Funae, Y.: Localization of rat cytochrome P450 in various tissues and comparison of arachidonic acid metabolism by rat P450 with that by human P450 orthologs. Drug Metab. Pharmacokinet., 20: 478-484 (2005).
24. Osada, M., Imaoka, S. and Funae, Y.: Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett., 575: 59-63 (2004).
25. Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S. and Danesh, F. R.: Diabetic nephropathy: mechanisms of renal disease progression. Exp. Biol. Med. (Maywood), 233: 4-11 (2008).
26. Imig, J. D.: Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases. Am. J. Physiol. Renal Physiol., 289: F496-503 (2005).
27. Huang, H., Chang, H. H., Xu, Y., Reddy, D. S., Du, J., Zhou, Y., Dong, Z., Falck, J. R. and Wang, M. H.: Epoxyeicosatrienoic Acid inhibition alters renal hemodynamics during pregnancy. Exp. Biol. Med. (Maywood), 231: 1744-1752 (2006).
28. Zhou, Y., Lin, S., Chang, H. H., Du, J., Dong, Z., Dorrance, A. M., Brands, M. W. and Wang, M. H.: Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet. Am. J. Hypertens., 18: 530-537 (2005).
29. Kraner, J. C., Lasker, J. M., Corcoran, G. B., Ray, S. D. and Raucy, J. L.: Induction of P4502E1 by acetone in isolated rabbit hepatocytes. Role of increased protein and mRNA synthesis. Biochem. Pharmacol., 45: 1483-1492 (1993).
30. Lee, H. S., Son, S. M., Kim, Y. K., Hong, K. W. and Kim, C. D.: NAD(P)H oxidase participates in the signaling events in high glucose-induced proliferation of vascular smooth muscle cells. Life Sci., 72: 2719-2730 (2003).
31. Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., Sano, H., Utsumi, H. and Nawata, H.: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 49: 1939-1945 (2000).
32. Schenkman, J. B., Thummel, K. E. and Favreau, L. V.: Physiological and pathophysiological alterations in rat hepatic cytochrome P-450. Drug Metab. Rev., 20: 557-584 (1989).
33. Dixon, R. L., Hart, L. G. and Fouts, J. R.: The metabolism of drugs by liver microsomes from alloxan-diabetic rats. J. Pharmacol. Exp. Ther., 133: 7-11 (1961).
34. Ren, B., Thelen, A. P., Peters, J. M., Gonzalez, F. J. and Jump, D. B.: Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha. J. Biol. Chem., 272: 26827-26832 (1997).
35. Liddle, C., Mode, A., Legraverend, C. and Gustafsson, J. A.: Constitutive expression and hormonal regulation of male sexually differentiated cytochromes P450 in primary cultured rat hepatocytes. Arch. Biochem. Biophys., 298: 159-166 (1992).
36. Hammock, B. D. and Ota, K.: Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities. Toxicol. Appl. Pharmacol., 71: 254-265 (1983).
37. Yu, Z., Xu, F., Huse, L. M., Morisseau, C., Draper, A. J., Newman, J. W., Parker, C., Graham, L., Engler, M. M., Hammock, B. D., Zeldin, D. C. and Kroetz, D. L.: Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res., 87: 992-998 (2000).
38. Sinal, C. J., Miyata, M., Tohkin, M., Nagata, K., Bend, J. R. and Gonzalez, F. J.: Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation. J. Biol. Chem., 275: 40504-40510 (2000).
39. Ma, J., Qu, W., Scarborough, P. E., Tomer, K. B., Moomaw, C. R., Maronpot, R., Davis, L. S., Breyer, M. D. and Zeldin, D. C.: Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. J. Biol. Chem., 274: 17777-17788 (1999).
40. Forbes, J. M., Coughlan, M. T. and Cooper, M. E.: Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes, 57: 1446-1454 (2008).
41. Ha, H. and Lee, H. B.: Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose. Kidney Int. Suppl., 77: S19-25 (2000).